Hyperbole, LH, is always interesting, but seldom useful. It is very true that the health care system in the US needs a significant amount of reform, especially in terms of coverage for those with lower than average incomes (who are those who most often lack health insurance) and in the context of pharmaceutical costs. However, your example is misplaced. My dad died of cancer earlier this year, and he also required extensive (and expensive) treatment in his last months. His care was paid for entirely through our tax-supported medical insurance program and the family's out-of-pocket expenses were minimal.